Cargando…

The prognostic and predictive value of serum CA19.9 in pancreatic cancer

BACKGROUND: Current staging methods for pancreatic cancer (PC) are inadequate, and biomarkers to aid clinical decision making are lacking. Despite the availability of the serum marker carbohydrate antigen 19.9 (CA19.9) for over two decades, its precise role in the management of PC is yet to be defin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Humphris, J. L., Chang, D. K., Johns, A. L., Scarlett, C. J., Pajic, M., Jones, M. D., Colvin, E. K., Nagrial, A., Chin, V. T., Chantrill, L. A., Samra, J. S., Gill, A. J., Kench, J. G., Merrett, N. D., Das, A., Musgrove, E. A., Sutherland, R. L., Biankin, A. V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2012
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387824/ https://www.ncbi.nlm.nih.gov/pubmed/22241899 http://dx.doi.org/10.1093/annonc/mdr561

Ejemplares similares

Adjuvant chemotherapy in elderly patients with pancreatic cancer
por: Nagrial, A M, et al.
Publicado: (2014)

Recruitment and Activation of Pancreatic Stellate Cells from the Bone Marrow in Pancreatic Cancer: A Model of Tumor-Host Interaction
por: Scarlett, Christopher J., et al.
Publicado: (2011)

Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer
por: Dreyer, Stephan B., et al.
Publicado: (2020)

Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma
por: Murphy, N C, et al.
Publicado: (2008)

Messina: A Novel Analysis Tool to Identify Biologically Relevant Molecules in Disease
por: Pinese, Mark, et al.
Publicado: (2009)

Clinical and molecular characterization of HER2 amplified-pancreatic cancer
por: Chou, Angela, et al.
Publicado: (2013)

Lost in translation: returning germline genetic results in genome-scale cancer research
por: Johns, Amber L., et al.
Publicado: (2017)

Retinoid Signaling in Pancreatic Cancer, Injury and Regeneration
por: Colvin, Emily K., et al.
Publicado: (2011)

Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities
por: Chin, Venessa T., et al.
Publicado: (2015)

Returning individual research results for genome sequences of pancreatic cancer
por: Johns, Amber L, et al.
Publicado: (2014)

The additive value of CA19.9 monitoring in a pancreatic cyst surveillance program
por: Levink, Iris J. M., et al.
Publicado: (2023)

The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma
por: Parkin, Ashleigh, et al.
Publicado: (2018)

BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast
por: Millar, E K A, et al.
Publicado: (2009)

Decay of /sup 199m, g/Po: isomeric transitions in /sup 199/PO and /sup 199/BI
por: Bingham, C R, et al.
Publicado: (1981)

Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer
por: Chou, Angela, et al.
Publicado: (2018)

Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer
por: Schultz, Nicolai A., et al.
Publicado: (2013)

Live or let die: oestrogen regulation of survival signalling in endocrine response
por: Butt, Alison J, et al.
Publicado: (2007)

The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome
por: Butt, Alison J, et al.
Publicado: (2008)

Study of the long-lived excited state in the neutron deficient nuclides $^{195,197,199}$Po by precision mass measurement
por: Althubiti, N.A., et al.
Publicado: (2017)

CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER(+ )disease
por: Sutherland, Robert L, et al.
Publicado: (2009)

Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models
por: Sutherland, Robert L, et al.
Publicado: (2002)

Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)
por: Phillips, D C, et al.
Publicado: (2015)

Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)
por: Phillips, D C, et al.
Publicado: (2016)

Tissue factor-bearing microparticles and CA19.9: two players in pancreatic cancer-associated thrombosis?
por: Woei-A-Jin, F J Sherida H, et al.
Publicado: (2016)

Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids()()
por: Sharbeen, G., et al.
Publicado: (2016)

Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer
por: Jahan, Rahat, et al.
Publicado: (2019)

Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer
por: Ali, Fahmy T., et al.
Publicado: (2022)

SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer
por: Harris, N L E, et al.
Publicado: (2017)

Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer
por: Chandrasegaram, Manju D, et al.
Publicado: (2017)

Common Activation of Canonical Wnt Signaling in Pancreatic Adenocarcinoma
por: Pasca di Magliano, Marina, et al.
Publicado: (2007)

Sex ratio of births in Ireland in 1978.
por: Walby, A. L., et al.
Publicado: (1981)

Trial of folic acid therapy in psoriasis.
por: Dawson, T. A., et al.
Publicado: (1978)

The limited streamer tubes for experiment PS199 at LEAR
por: Birsa, R, et al.
Publicado: (1990)

Clearance of systemic hematologic tumors by venetoclax (Abt-199) and navitoclax
por: Ackler, Scott, et al.
Publicado: (2015)

Orientation of $^{199m}$Hg by optical pumping detected by $\gamma$-radiation anisotropy
por: Bonn, J, et al.
Publicado: (1975)

Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells
por: Kang, Jian, et al.
Publicado: (2014)

ABT‐199 (Venetoclax), a BH3‐mimetic Bcl‐2 inhibitor, does not cause Ca(2+)‐signalling dysregulation or toxicity in pancreatic acinar cells
por: Jakubowska, Monika A, et al.
Publicado: (2018)

Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients
por: Xu, Wei-Yu, et al.
Publicado: (2018)

AMnO(3) (A = Sr, La, Ca, Y) Perovskite Oxides as Oxygen Reduction Electrocatalysts
por: Celorrio, V., et al.
Publicado: (2018)

Routine measurement of haemoglobin A1 at the diabetic outpatient clinic.
por: Byrne, E., et al.
Publicado: (1984)

Cannot write session to /tmp/vufind_sessions/sess_lmennovv0dk7h2f70jrmrqtpo2